Our research work focuses on the contribution of post-transcriptional mechanisms on cancer cell adaptation, in particular RNA epigenetic & translational control.
| Added by | amaraver |
|---|---|
| Group name | EquipeAM |
| Item Type | Attachment |
| Title | Full Text |
| URL | https://www.lungcancerjournal.info/article/S0169500222000435/pdf |
| Accessed | 2022/08/31 - 16:14:12 |
| Date Added | 2022/08/31 - 14:14:12 |
| Date Modified | 2022/08/31 - 14:14:12 |
| Parent item | Characterizing immune-mediated adverse events with durvalumab in patients with unresectable stage III NSCLC: A post-hoc analysis of the PACIFIC trial |
Located in the Parc Euromédecine, the Institut de Recherche en Cancérologie de Montpellier (U1194) is located on the Val d'Aurelle Campus (ICM, Institut régional du Cancer Montpellier/ Val d'Aurelle).
U1194 Research Centre supported by Inserm, the University of Montpellier and the Institut du Cancer de Montpellier (ICM)
Institut de Recherche en Cancérologie de